Intellia Therapeutics saw the highest growth of 1.7% in patent filings and 1.32% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.63% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Intellia Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Intellia Therapeutics has been focused on protecting inventions in Chile(CL) with six publications in Q2 2024
The Chile(CL) Patent Office dominates the patent filings with nearly 26% of filings. The Chile(CL), Israel(IL), United States(US), and Australia(AU) patent Office are among the top ten patent offices where Intellia Therapeutics is filings its patents. Among the top granted patent authorities, Intellia Therapeutics has 25% of its grants in Israel(IL) and 12% in United States(US).
In terms of grant share, Intellia Therapeutics stands in seventh position among its competitors. and secured the top positions according to recent patent publication data.
Patents related to nanomedicine and genomics lead Intellia Therapeutics's portfolio
Intellia Therapeutics has the highest number of patents in nanomedicine followed by, genomics and rare diseases. For nanomedicine, nearly 55% of patents were filed and 86% of patents were granted in Q2 2024.
Hemoglobinopathies related patents lead Intellia Therapeutics portfolio followed by amyloidosis, and congestive heart failure (heart failure)
Intellia Therapeutics has highest number of patents in hemoglobinopathies followed by amyloidosis, congestive heart failure (heart failure), neuropathy, and alpha-1 antitrypsin deficiency (a1ad). For hemoglobinopathies, nearly 10% of patents were filed and 25% of patents were granted in Q2 2024.
For comprehensive analysis of Intellia Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
